Cempra's 7.25 Million shares sold at 14% discount 10:13 a.m. June 14, 2013 - MarketWatch.com
Modest gains for Cempra's IPO in trading debut 1:27 p.m. Feb. 3, 2012 - MarketWatch.com
Cempra (CEMP) Highlighted As Today's Perilous Reversal Stock 10:07 a.m. Dec. 19, 2014 - TheStreet.com
Cempra (CEMP) Worth Watching: Stock Moves 7.2% Higher - Tale of the Tape 9:25 a.m. Dec. 19, 2014 - Zacks.com
New Lifetime High Reached: Cempra (CEMP) 9:46 a.m. Dec. 18, 2014 - TheStreet.com
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know 9:20 a.m. Dec. 17, 2014 - TheStreet.com
Cempra (CEMP) Is Today's Strong On High Volume Stock 10:13 a.m. Dec. 12, 2014 - TheStreet.com
Will Cempra (CEMP) Continue to Surge Higher? - Tale of the Tape 9:20 a.m. Dec. 11, 2014 - Zacks.com
Analysts say two biotech firms may be targets after Merck-Cubist deal 1:20 p.m. Dec. 9, 2014 - Seeking Alpha
Cempra (CEMP) Reaches New Lifetime High Today 9:45 a.m. Dec. 9, 2014 - TheStreet.com
Cempra (CEMP) in Focus: Stock Rises 11.4% in Session - Tale of the Tape 8:37 a.m. Dec. 9, 2014 - Zacks.com
Can Cempra (CEMP) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape 8:52 a.m. Dec. 5, 2014 - Zacks.com
Cempra Poised To Join Antibacterial Drug Acquisition Buzz With Upcoming Data Release 8:00 a.m. Nov. 25, 2014 - Seeking Alpha
Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak 4:24 p.m. Nov. 13, 2014 - Seeking Alpha
Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher - Tale of the Tape 9:25 a.m. Nov. 13, 2014 - Zacks.com
Moving Average Crossover Alert: Cempra (CEMP) - Tale of the Tape 9:10 a.m. Nov. 6, 2014 - Zacks.com
Why Cempra (CEMP) Could Be Positioned for a Surge? - Tale of the Tape 8:31 a.m. Nov. 6, 2014 - Zacks.com
Moving Average Crossover Alert: Cempra (CEMP) - Tale of the Tape 6:16 a.m. Nov. 4, 2014 - Zacks.com
Strength Seen in Cempra (CEMP): Stock Rises 10.1% - Tale of the Tape 9:25 a.m. Oct. 31, 2014 - Zacks.com
Cempra's (CEMP) CEO Prabha Fernandes on Q3 2014 Results - Earnings Call Transcript 11:16 p.m. Oct. 29, 2014 - Seeking Alpha
10-Q: CEMPRA, INC. 4:08 p.m. Oct. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings after Wednesday’s close 5:35 p.m. Oct. 28, 2014 - Seeking Alpha
Cempra to Participate in Upcoming Investor Events in December 4:11 p.m. Dec. 3, 2014 - GlobeNewswire
Cempra to Receive BARDA Funding for 1b and Start-Up of Phase 2/3 Solithromycin Pediatric Studies 6:01 a.m. Nov. 19, 2014 - GlobeNewswire
Cempra to Present at Two Upcoming Investor Conferences 4:07 p.m. Nov. 10, 2014 - GlobeNewswire
Cempra Reports Third Quarter 2014 Financial Results and Provides Corporate Update 3:07 p.m. Oct. 29, 2014 - GlobeNewswire
Cempra Completes Enrollment of Solitaire-Oral Phase 3 Trial 3:05 p.m. Sept. 25, 2014 - GlobeNewswire
Cempra, Inc. Receives $10 Million Milestone Payment From Toyama Chemical Co. Triggered by Solithromycin's Clinical Development Progress in Japan 7:01 a.m. Sept. 9, 2014 - GlobeNewswire
Cempra, Inc. to Present at Three Investor Conferences 3:06 p.m. Aug. 27, 2014 - GlobeNewswire
Cempra Initiates Phase 3 Clinical Trial in Patients With Uncomplicated Gonorrhea Infection 7:01 a.m. Aug. 12, 2014 - GlobeNewswire
Cempra, Inc. Reports Second Quarter 2014 Financial and Operating Results 3:06 p.m. July 29, 2014 - GlobeNewswire
Cempra, Inc. to Report Second Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on July 29, 2014 3:06 p.m. July 22, 2014 - GlobeNewswire
Cempra, Inc. to Present at JMP Securities Healthcare Conference 3:05 p.m. June 17, 2014 - GlobeNewswire
Wall Street In and Out of Love with NASH Drug Developers 9:21 a.m. May 13, 2014 - ACCESSWIRE
Cempra, Inc. to Present at Three Investor Conferences 3:01 p.m. May 8, 2014 - GlobeNewswire
Cempra, Inc. Reports First Quarter 2014 Financial and Operating Results 3:02 p.m. April 29, 2014 - GlobeNewswire
Cempra, Inc. to Report First Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on April 29, 2014 3:06 p.m. April 22, 2014 - GlobeNewswire
Treatments for Non-Alcoholic Steatohepatitis Making Clinical Strides 10:01 a.m. April 8, 2014 - ACCESSWIRE
Cempra's Solithromycin Demonstrates Therapeutic Potential Beyond Anti-Bacterial Activity 3:06 p.m. April 3, 2014 - GlobeNewswire
Cempra to Present Late-Breaker on Solithromycin Reducing Inflammation in an Animal Model for Cancer Chemotherapy-Induced Lung Injury 7:14 a.m. March 27, 2014 - GlobeNewswire
Cempra, Inc. to Present at The 21st Annual Future Leaders in the Biotech Industry Conference and Needham & Co. 12th Annual Healthcare Conference 3:12 p.m. March 20, 2014 - GlobeNewswire
Cempra, Inc. to Present at Barclays Capital 2014 Global Healthcare Conference and 26th Annual ROTH Conference 3:59 a.m. March 7, 2014 - GlobeNewswire